Nektar Therapeutics Inc. (ITH0)
Market Closed
17 Jul, 20:00
€
59. 54
+1.34
+2.3024%
€
- Market Cap
- P/E Ratio
- Div Yield
24 Volume
-0.72 Eps
€ 58.2
Previous Close Want to track ITH0 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Nektar Therapeutics Inc. (ITH0) Statistics
Valuation metrics
Market Cap -
Enterprise value 70.64M
Trailing P/E (ttm) -6.02
Forward P/E -
PEG ratio 0.12
Price/Sales (ttm) -
Price/Book (mrq) 2.52
Enterprise Value/Revenue 1.28
Enterprise Value/EBITDA -0.59
Overview
Shares outstanding 29.47M
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 101
Average volume (90 days) 65
Price summary
52-Week low 18.9
52-Week high 87.52
Beta -
50-Day moving average 67.16
200-Day moving average 48.81
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:15
Last split Date 9 Jun 2025
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026
Profitability
Profit margin 1%
Operating margin -2.34%
Operational effectiveness
Return on assets -0.59%
Return on equity -1.83%
Income Statement
Revenue (ttm) 55.23M
Revenue per share (ttm) 3.27
Quarterly revenue growth (yoy) -0.5%
Gross profit (ttm) 55.23M
EBITDA -
Net income to common (ttm) -164.08M
Diluted EPS (ttm) -9.73
Quarterly earnings growth (yoy) 0.04%
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) -
Total debt (mrq) 83.16M
Total Debt/Equity (mrq) 0.14
Current ratio (mrq) 10.21%
Book value per share (mrq) 23.29
Cash Flow
Cash flow statement -210.38M
Levered free cash flow (LFCF) -164.08M
